- Home
- TOPS vs AKTX Comparison
TOPS vs AKTX Comparison
Compare TOPS & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPS
- AKTX
- Stock Information
- Founded
- TOPS 2000
- AKTX N/A
- Country
- TOPS Greece
- AKTX United States
- Employees
- TOPS N/A
- AKTX N/A
- Industry
- TOPS Marine Transportation
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- TOPS Consumer Discretionary
- AKTX Health Care
- Exchange
- TOPS Nasdaq
- AKTX Nasdaq
- Market Cap
- TOPS 31.1M
- AKTX 34.7M
- IPO Year
- TOPS 2004
- AKTX N/A
- Fundamental
- Price
- TOPS $6.78
- AKTX $1.19
- Analyst Decision
- TOPS
- AKTX
- Analyst Count
- TOPS 0
- AKTX 0
- Target Price
- TOPS N/A
- AKTX N/A
- AVG Volume (30 Days)
- TOPS 15.3K
- AKTX 67.9K
- Earning Date
- TOPS 08-09-2024
- AKTX 02-15-2025
- Dividend Yield
- TOPS N/A
- AKTX N/A
- EPS Growth
- TOPS N/A
- AKTX N/A
- EPS
- TOPS N/A
- AKTX N/A
- Revenue
- TOPS $83,870,000.00
- AKTX N/A
- Revenue This Year
- TOPS $7.10
- AKTX N/A
- Revenue Next Year
- TOPS $6.54
- AKTX N/A
- P/E Ratio
- TOPS N/A
- AKTX N/A
- Revenue Growth
- TOPS 1.10
- AKTX N/A
- 52 Week Low
- TOPS $5.30
- AKTX $0.90
- 52 Week High
- TOPS $14.94
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- TOPS 50.38
- AKTX 47.06
- Support Level
- TOPS $6.70
- AKTX $1.13
- Resistance Level
- TOPS $7.60
- AKTX $1.27
- Average True Range (ATR)
- TOPS 0.40
- AKTX 0.12
- MACD
- TOPS 0.09
- AKTX 0.03
- Stochastic Oscillator
- TOPS 55.79
- AKTX 44.92
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The company focuses on the transportation of petroleum products (clean and dirty) and bulk liquid chemicals. The Company is an international provider of worldwide oil, petroleum products and chemical transportation services. It generates revenue from the Time Charter agreements.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).